Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 18024322)

1.

Angiogenesis in myeloproliferative neoplasms, new markers and future directions.

Medinger M, Passweg J.

Memo. 2014;7:206-210. Epub 2014 May 22. Review.

2.

The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia.

Koopmans SM, Bot FJ, Schouten HC, Janssen J, van Marion AM.

Am J Blood Res. 2012;2(2):119-27. Epub 2012 May 25.

3.

Clinical trials with anti-angiogenic agents in hematological malignancies.

Medinger M, Mross K.

J Angiogenes Res. 2010 Jun 22;2:10. doi: 10.1186/2040-2384-2-10.

4.

Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.

Medinger M, Fischer N, Tzankov A.

J Oncol. 2010;2010:729725. doi: 10.1155/2010/729725. Epub 2010 May 24.

5.
6.

CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.

Tripodo C, Di Bernardo A, Ternullo MP, Guarnotta C, Porcasi R, Ingrao S, Gianelli U, Boveri E, Iannitto E, Franco G, Florena AM.

Haematologica. 2009 Jan;94(1):127-30. doi: 10.3324/haematol.13598. Epub 2008 Nov 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk